| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/23/2007 | US7166291 Allergenic proteins and peptides from dog dander and uses therefor |
| 01/23/2007 | US7166286 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for prophylaxis and detection of cancers |
| 01/23/2007 | US7166285 Anti-IL-12 antibodies and compositions |
| 01/23/2007 | US7166283 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 01/23/2007 | US7166278 Using swine organs; controlling gene expression |
| 01/23/2007 | US7166213 Solid compositions for selective adsorption from complex mixtures |
| 01/23/2007 | CA2326389C Novel cd19xcd3 specific polypeptides and uses thereof |
| 01/18/2007 | WO2007008870A2 Transgenic mice carrying hp-2 gene and uses as models for vascular diseases |
| 01/18/2007 | WO2006113220A3 Transgenic mammals expressing human preproinsulin |
| 01/18/2007 | WO2006110164A3 Deactivation of linking moieties in antibody-enzyme conjugates |
| 01/18/2007 | WO2006065272A3 Methods for altering acetic acid production and enhancing cell death in bacteria |
| 01/18/2007 | WO2006061174A3 Rhamnose promoter expression system |
| 01/18/2007 | WO2006028595A3 Muteins of fibroblast growth factor 21 |
| 01/18/2007 | WO2005124341A8 Stable isotope labeled polypeptide standards for protein quantitation |
| 01/18/2007 | WO2005098043A3 Ligand-dependent protein splicing |
| 01/18/2007 | WO2004042348A3 Methods for the identification of inhibitors of chitin synthase 2, s-adenosylmethionine decarboxylase, putrescine aminopropyltransferase, and methylenetetrahydrofolate reductase as antibiotics |
| 01/18/2007 | WO2003089582A3 Multimeric ligands with enhanced stability |
| 01/18/2007 | US20070016970 Guinea pig-chymase |
| 01/18/2007 | US20070016969 Expression vector for hirudin and transformed cells and transgenic animals containing said vector |
| 01/18/2007 | US20070016967 Novel IFNgamma-like polypeptides |
| 01/18/2007 | US20070015907 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 01/18/2007 | US20070015700 Mammalian genes modulated during fasting and feeding |
| 01/18/2007 | US20070015699 provide for inhibition of tumor necrosis factor -TNF alpha signal transduction and the associated immune inflammatory responses; used in treatment of Crohn's disease, psoriasis, rheumatoid arthritis, graft versus host disease etc; vector; isolated cell |
| 01/18/2007 | US20070015679 Polypeptides having branching enzyme activity and nucleic acids encoding same |
| 01/18/2007 | US20070015677 hydrolase enzymes comprising amino acid sequence having replacements, deletions or insertion , used in cleaning compounds or detergents having improved wash performance on egg stains |
| 01/18/2007 | US20070015347 Strain modulation employing process techniques for CMOS technologies |
| 01/18/2007 | US20070015266 Using amylase to hydrolyze starch for use in fermentation of ethanol |
| 01/18/2007 | US20070015265 Derived from Achromobacter xylosoxidans; improved thermostability, storage stability and cost efficiency; industrial scale production of a 2-keto-3-deoxyaldonic acid |
| 01/18/2007 | US20070015259 Fusion partner for production of monoclonal rabbit antibodies |
| 01/18/2007 | US20070015258 Alpha-beta C4BP -type recombinant heteromultimeric proteins |
| 01/18/2007 | US20070015257 Alpha-MSH related compounds and methods of use |
| 01/18/2007 | US20070015254 Crystal harvest from fermentation broth |
| 01/18/2007 | US20070015253 Heterologous; biologically active protein fused via a proteolytic cleavage site to a latency associated peptide which having a precursor domain of transforming growth factor beta; overcomes the toxic effect of systemic administration of potent biological agents |
| 01/18/2007 | US20070015252 Corynebacterium glutamicum genes encoding regulatory proteins |
| 01/18/2007 | US20070015251 Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins |
| 01/18/2007 | US20070015250 Methods and compositions for increasing longevity and protein yield from a cell culture |
| 01/18/2007 | US20070015249 Chondroitin polymerase and DNA encoding the same |
| 01/18/2007 | US20070015248 Expression vector and use thereof |
| 01/18/2007 | US20070015247 Apolipoprotein receptor specific monoclonal antibody for use in the prevention and treatment of cell proliferative disorders |
| 01/18/2007 | US20070015246 STAMP2 nucleic acid molecules; urogenital system for detection, prevention and treatment of cancer |
| 01/18/2007 | US20070015245 Production of a highly active, soluble form of the cytochrome P450 reductase (CPR A) from Candida tropicalis |
| 01/18/2007 | US20070015244 System for antibody expression and assembly |
| 01/18/2007 | US20070015243 fusion protein capable of forming a virus-like particle; useful in vaccination, therapy or diagnosis; consisting of an IBDV pVP2 protein bound to a heterologous polypeptide comprising a polypeptide of interest |
| 01/18/2007 | US20070015242 Expression vector comprising nucleotide sequences coding C-terminal 28kDa endostatin-spanning proteolytic fragment for use in prevention and treatment of vision defcets associated with cell proliferative disorders |
| 01/18/2007 | US20070015241 Sulfur atom-free enzyme protein |
| 01/18/2007 | US20070015239 Correlation between the fucose content/galactose content ratio of anti-rhesus-d and anti-hla-dr antibodies and the adcc activity |
| 01/18/2007 | US20070015238 Production of pseudotyped recombinant AAV virions |
| 01/18/2007 | US20070015229 Secretory or membrane-binding chimeric protein |
| 01/18/2007 | US20070015220 Novel guanosine triphosphate (GTP) binding protein-coupled receptor proteins |
| 01/18/2007 | US20070015219 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 01/18/2007 | US20070015217 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease |
| 01/18/2007 | US20070015211 Conformer-specific antibodies and method of use, thereof |
| 01/18/2007 | US20070015207 Such as 1-dimethylamino-3-[4-(3-indan-5-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamino)-phenoxy]-propan-2-ol; serine-tyrosine and tyrosine kinase inhibitors; cancer, metastasis |
| 01/18/2007 | US20070015201 Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor |
| 01/18/2007 | US20070015199 Stabilized immunogenic HBc chimer particles |
| 01/18/2007 | US20070015196 Growth factor with acts through Erb B-4 RTK |
| 01/18/2007 | US20070015193 Glutathione S-transferase sequence variants |
| 01/18/2007 | US20070015173 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 01/18/2007 | US20070015164 Dairy cattle breeding for improved milk production traits in cattle |
| 01/18/2007 | US20070015163 Novel full-length cDNA |
| 01/18/2007 | US20070015155 Novel protein usable in screening drug improving type 2 diabetes |
| 01/18/2007 | US20070015150 Novel nucleic acid sequences and proteins of tumors and neoplasias of the thyroid gland |
| 01/18/2007 | US20070015149 Prlz regulatory elements in the treatment of disease and the discovery of therapeutics |
| 01/18/2007 | US20070015144 Human cDNAs and proteins and uses thereof |
| 01/18/2007 | US20070014813 Immunogenic polypeptide comprising adjuvant (alum); coupled to diphtheria toxoid; diagnosis and treatment |
| 01/18/2007 | US20070014807 Multiplex vaccine |
| 01/18/2007 | US20070014802 Modified antibody fragments |
| 01/18/2007 | US20070014800 Cytokine zalpha11 ligand antibodies |
| 01/18/2007 | US20070014799 Antibody and use of the same |
| 01/18/2007 | US20070014798 Antibodies to dendritc cells and human dendritic cell populations and uses thereof |
| 01/18/2007 | US20070014796 Method for the production of non-immunogenic proteins |
| 01/18/2007 | US20070014794 preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras; yields of the heteromultimer over other unwanted end-products such as homomultimers |
| 01/18/2007 | US20070014793 Antibodies which activate an erythropoietin receptor |
| 01/18/2007 | US20070014787 71 human secreted proteins |
| 01/18/2007 | US20070014778 Endoribonuclease and uses thereof |
| 01/18/2007 | US20070014776 Identification of adiponutrin-related proteins as esterases and methods of use for the same |
| 01/18/2007 | US20070014766 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 01/18/2007 | US20070014761 Heterodimeric four helix bundle cytokines |
| 01/18/2007 | US20070014759 Glycopegylated granulocyte colony stimulating factor |
| 01/18/2007 | US20070014724 inhibit the biological activity of multiple interferon (IFN) alpha subtypes but do not substantially inhibit the biological activity of IFN alpha 21, IFN beta or IFN omega; autoimmune diseases, transplant rejection and graft versus host disease; immunoconjugates |
| 01/18/2007 | US20070014720 Antibodies directed to CD20 and uses thereof |
| 01/18/2007 | DE102006012317A1 New macromolecular compounds comprising nucleotide and nucleoside building blocks, are useful in enzymatic reactions and nucleic acid analysis |
| 01/18/2007 | CA2614952A1 Method of treating human volume expansion mediated hypertension employing resibufogenin |
| 01/18/2007 | CA2614183A1 Anti-alpha v beta 6 antibodies and uses thereof |
| 01/18/2007 | CA2613348A1 Transgenic mice carrying hp-2 gene and uses as models for vascular diseases |
| 01/17/2007 | EP1743941A1 Novel mite allergen |
| 01/17/2007 | EP1743940A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/17/2007 | EP1743172A2 Detection and quantification of intracellular pathogens |
| 01/17/2007 | EP1743043A2 High throughput discovery of materials through vapor phase synthesis |
| 01/17/2007 | EP1742658A2 Cellular permissivity factor for viruses, and uses thereof |
| 01/17/2007 | EP1742656A2 Novel peanut skin extract as a vaccine adjuvant |
| 01/17/2007 | EP1654379A4 Methods and compositions for enhanced protein expression and purification |
| 01/17/2007 | EP1368474B1 Polynucleotide useful for modulating cancer cell proliferation |
| 01/17/2007 | EP1349945B1 Method for the production of a heterologous protein by a fungus |
| 01/17/2007 | EP1326995B1 Method for synthesising peptides, peptide mimetics and proteins |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1224314B1 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 01/17/2007 | EP1179539B1 Protein having hemolytic activity and gene encoding the protein |
| 01/17/2007 | EP1087996B1 Glycosulfopeptides and methods of synthesis and use thereof |
| 01/17/2007 | EP1078072B1 New peptide fragments for protein purification |